1,712 Shares in GE HealthCare Technologies Inc. (NASDAQ:GEHC) Bought by Millstone Evans Group LLC

Millstone Evans Group LLC bought a new position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund bought 1,712 shares of the company’s stock, valued at approximately $134,000.

Other institutional investors and hedge funds have also bought and sold shares of the company. Cathy Pareto & Associates Inc. bought a new position in GE HealthCare Technologies during the fourth quarter worth $670,000. Principal Financial Group Inc. increased its holdings in GE HealthCare Technologies by 1.9% in the 3rd quarter. Principal Financial Group Inc. now owns 1,009,910 shares of the company’s stock valued at $94,780,000 after buying an additional 19,010 shares during the period. B. Metzler seel. Sohn & Co. Holding AG bought a new stake in GE HealthCare Technologies in the 3rd quarter valued at $1,396,000. Everence Capital Management Inc. increased its holdings in GE HealthCare Technologies by 118.2% in the 4th quarter. Everence Capital Management Inc. now owns 18,870 shares of the company’s stock valued at $1,475,000 after buying an additional 10,220 shares during the period. Finally, Nomura Asset Management Co. Ltd. increased its holdings in GE HealthCare Technologies by 9.7% in the 3rd quarter. Nomura Asset Management Co. Ltd. now owns 145,996 shares of the company’s stock valued at $13,702,000 after buying an additional 12,908 shares during the period. Institutional investors own 82.06% of the company’s stock.

GE HealthCare Technologies Stock Down 0.4 %

Shares of NASDAQ GEHC opened at $81.49 on Friday. GE HealthCare Technologies Inc. has a 12-month low of $74.51 and a 12-month high of $94.80. The firm’s 50-day simple moving average is $87.02 and its 200 day simple moving average is $86.03. The company has a quick ratio of 0.83, a current ratio of 1.04 and a debt-to-equity ratio of 0.88. The company has a market cap of $37.27 billion, a price-to-earnings ratio of 18.82, a price-to-earnings-growth ratio of 3.19 and a beta of 1.13.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its quarterly earnings data on Thursday, February 13th. The company reported $1.45 EPS for the quarter, topping analysts’ consensus estimates of $1.26 by $0.19. GE HealthCare Technologies had a net margin of 10.13% and a return on equity of 25.74%. The firm had revenue of $5.32 billion for the quarter, compared to analyst estimates of $5.33 billion. On average, research analysts expect that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several equities research analysts have issued reports on the stock. Jefferies Financial Group raised shares of GE HealthCare Technologies from a “hold” rating to a “buy” rating and boosted their price target for the company from $95.00 to $103.00 in a report on Wednesday, January 8th. The Goldman Sachs Group raised shares of GE HealthCare Technologies from a “neutral” rating to a “buy” rating and boosted their price target for the company from $85.00 to $100.00 in a report on Tuesday, March 11th. Wells Fargo & Company boosted their price target on shares of GE HealthCare Technologies from $96.00 to $103.00 and gave the company an “overweight” rating in a report on Friday, February 14th. Finally, Citigroup boosted their price target on shares of GE HealthCare Technologies from $103.00 to $110.00 and gave the company a “buy” rating in a report on Thursday, February 13th. One analyst has rated the stock with a sell rating, two have given a hold rating, nine have assigned a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $98.75.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.